Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 2, 1998, Pages 383-392

  Baines, Christopher P ^a   Wang, Lei ^a   Cohen, Michael V ^a   Downey, James M ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Anisomycin; Genistein; Ischemic preconditioning; Lavendustin A; Mitogen activated protein kinase; Protein kinase C; Tyrosine kinase

Indexed keywords

ANISOMYCIN; CHELERYTHRINE; GENISTEIN; LAVENDUSTIN A; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION;

EID: 0032004952     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0601     Document Type: Article

References (49)

1. F527 in vitro and in intact cells. Eur J Pharmacol 269: 1-8.
2. AKIYAMA T, ISHIDA J, NAKAGAWA S, OGAWARA H, WATANABE S-I, ITOH N, SHIBUYA M, FUKAMI Y, 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262: 5592-5595.
3. BHAT NR, ZHANG P, HOGAN EL, 1995. Thrombin activates mitogen-activated protein kinase in primary astrocyte cultures. J Cell Physiol 165: 417-424.
4. CHEN Y-H, POUYSSÉGUR J, COURTNEIDGE SA, VAN OBBERGHEN-SCHILLING E, 1994. Activation of Src family kinase activity by the G protein-coupled thrombin receptor in growth-responsive flbroblasts. J Biol Chem 269: 27372-27377.
5. CHEN Y-H, GRALL D, SALCINI AE, PELICCI PG, POUYSSÉGUR J, VAN OBBERGHEN-SCHILLING E, 1996. She adaptor proteins are key transducers of mitogenic signaling mediated by the G protein-coupled thrombin receptor. EMBO J 15: 1037-1044.
6. COHEN MV, DOWNEY JM, 1995. Preconditioning during ischemia: basic mechanisms and potential clinical applications. Cardiol Rev 3: 137-149.
7. COHEN MV, LIU Y, LUI GS, WANG P, WEINBRENNER C, CORDIS GA, DAS DK, DOWNEY JM, 1996. Phospholipase D plays a role in ischemic preconditioning in rabbit heart. Circulation 94: 1713-1718.
8. GEISSLER JF, TRAXLER P, REGENASS U, MURRAY BJ, ROESEL JL, MEYER T, MCGLYNN E, STORNI A, LYDON NB, 1990. Thiazolidine-diones: biochemical and biological activity of a novel class of tyrosine protein kinase inhibitors. J Biol Chem 265: 22255-22261.
9. GOTO M, LIU Y YANG X-M, ARDELL JL, COHEN MV, DOWNEY JM, 1995. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77: 611-621.
10. HSU C-YJ, PERSONS PE, SPADA AP, BEDNAR RA, LEVITZKI A, ZILBERSTEIN A, 1991. Kinetic analysis of the inhibition of the epidermal growth factor receptor tyrosine kinase by lavendustin-A and its analogue. J Biol Chem 266: 21105-21112.
11. HTUN P, ITO W, KIRSCH K-P, SCHAPER W, 1996. Acidic fibroblast growth factor protects ischemic myocardium. J Mol Cell Cardiol 28: A45 [Abstract].
12. IKONOMIDIS JS, SHIRAI T, WEISEL RD, DERYLO B, RAO V, WHITESIDE CI, MICKLE DAG, LI R-K, 1997. Preconditioning cultured human pediatric myocytes requires adenosine and protein kinase C. Am J Physiol 272: H1220-H1230.
13. KAZLAUSKAS A, COOPER JA, 1989. Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins. Cell 58: 1121-1133.
14. KHALIL RA, MENICE CB, WANG C-LA, MORGAN KG, 1995. Phosphotyrosine-dependent targeting of mitogen-activated protein kinase in differentiated contractile vascular cells. Circ Res 76: 1101-1108.
15. KIM HK, KIM JW, ZILBERSTEIN A, MARGOLIS B, KIM JG, SCHLESSINGER J, RHEE SG, 1991. PDGF stimulation of inositol phospholipid hydrolysis requires PLC-γ1 phosphorylation on tyrosine residues 783 and 1254. Cell 65: 435-441.
16. KITAKAZE M, NODE K, MINAMINO T, KOMAMURA K, FUNAYA H, SHINOZAKI Y, CHUJO M, MORI H, INOUE M, HORI M, KAMADA T, 1996. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preγ conditioning through activation of ecto-5′-nucleotidase. Circulation 93: 781-791.
17. KOZAWA O, SUZUKI A, OISO Y, 1995. Tyrosine kinase regulates phospholipase D activation at a point down-stream from protein kinase C in osteoblast-like cells. J Cell Biochem 57: 251-255.
18. LANIYONU AA, SAIFEDDINE M, YANG S-G, HOLLENBERG MD, 1994. Tyrosine kinase inhibitors and the contractile action of G-protein-linked vascular agonists. Can J Physiol Pharmacol 72: 1075-1085.
19. 2+ entry by tyrosine kinase inhibitors. J Biol Chem 268: 9945-9948.
20. LIU B, NAKASHIMA S, KANOH H, TAKANO T, SHIMIZU T, NOZAWA Y, 1994. Activation of phospholipase D in Chinese hamster ovary cells expressing platelet-activating factor receptor. J Biochem 116: 882-891.
21. LIU Y, COHEN MV, DOWNEY JM, 1994. Chelerythrine, a highly selective protein kinase C inhibitor, blocks the antiinfarct effect of ischemic preconditioning in rabbit hearts. Cardiovasc Drugs Ther 8: 881-882.
22. LIU Y, TSUCHIDA A, COHEN MV, DOWNEY JM, 1995. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol 27: 883-892.
23. MARGOLIS B, RHEE SG, FELDER S, MERVIC M, LYALL R, LEVITZKI A, ULLRICH A, ZILBERSTEIN A, SCHLESSINGER J, 1989. EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling. Cell 57: 1101-1107.
24. MAULIK N, WATANABE M, ZU Y-L, HUANG C-K, CORDIS GA, SCHLEY JA, DAS DK, 1996. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 396: 233-237.
25. MORTON C, WILKIE N, BOARDER MR, 1995. Tyrosine phosphorylation, MAPK and PLD in All stimulated mitogenesis. Biochem Soc Trans 23: 426S [Abstract].
26. MUSTELIN T, COGGESHALL KM, ISAKOV N, ALTMAN A, 1990. T cell antigen receptor-mediated activation of phospholipase C requires tyrosine phosphorylation. Science 247: 1584-1587.
27. NISHIBE S, WAHL MI, HERNÁNDEZ-SOTOMAYOR SMT, TONKS NK, RHEE SG, CARPENTER G, 1990. Increase of the catalytic activity of phospholipase C-γ1 by tyrosine phosphorylation. Science 250: 1253-1256.
28. O'DELL TJ, KANDEL ER, GRANT SGN, 1991. Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors. Nature 353: 558-560.
29. OFFERMANNS S, BOMBIEN E, SCHULTZ G, 1993. Stimulation of tyrosine phosphorylation and mitogen-activated-protein (MAP) kinase activity in human SH-SY5Y neuroblastoma cells by carbachol. Biochem J 294: 545-550.
30. OGAWA W, HOSOMI Y, ROTH RA, 1995. Activation of protein kinase C stimulates the tyrosine phosphorylation and guanosine triphosphatase-activating protein association of P60 in rat hepatoma cells. Endocrinology 136: 476-481.
31. ONODA T, IINUMA H, SASAKI Y, HAMADA M, ISSHIKI K, NAGANAWA H, TAKEUCHI T, TATSUTAK K, UMEZAWA K, 1989. Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus. J Nat Prod 52: 1252-1257.
32. PRYZKLENK K, SUSSMAN MA, SIMKHOVICH BZ, KLONER RA, 1995. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model? Circulation 92: 1546-1557.
33. 3 generation. Biochem J 318: 723-728.
34. RAINGEAUD J, WHITMARSH AJ, BARRETT T, DÉRIJARD B, DAVIS RJ, 1996. MKK3-and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 16: 1247-1255.
35. RÖNNSTRAND L, MORI S, ARRIDSSON A-K, ERIKSSON A, WERNSTEDT C, HELLMAN U, CLAESSON-WELSH L, HELDIN C-H, 1992. Identification of two C-terminal autophosphorylation sites in the PDGF β-receptor: involvement in the interaction with phospholipase C-γ. EMBO J 11: 3911-3919.
36. ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes. EMBO J 15: 775-787.
37. 2+-dependent signaling. Circ Res 76: 1-15.
38. SEGER R, BIENER Y, FEINSTEIN R, HANOCH T, GAZIT A, ZICK Y, 1995. Differential activation of mitogen-activated protein kinase and S6 kinase signaling pathways by 12-O-Tetradecanoylphorbol-13-acetate (TPA) and insulin. J Biol Chem 270: 28325-28330.
39. c-src. J Biol Chem 268: 9347-9357.
40. SPEECHLY-DICK ME, MOCANU MM, YELLON DM, 1994. Protein kinase C: its role in ischemic preconditioning in the rat. Circ Res 75: 586-590.
41. + channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res 77: 1030-1035.
42. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 75: 576-585.
43. VAHLHAUS C, SCHULZ R, POST H, ONALLAH R, HEUSCH G, 1996. No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine. Circ Res 79: 407-414.
44. VOGT A, HTUN P, KLUGE A, ZIMMERMANN R, SCHAPER W, 1997. Insulin-like growth factor-II delays myocardial infarction in experimental coronary artery occlusion. Cardiovasc Res 33: 469-477.
45. WANG P, GALLAGHER KP, DOWNEY JM, COHEN MV, 1996. Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart. J Mol Cell Cardiol 28: 579-588.
46. WEINBRENNER C, LIN G-S, COHEN MV, DOWNEY JM, 1997. Phosphorylation of tyrosine-182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J Mol Cell Cardiol 29: 2383-2391.
47. YANG X-M, SATO H, DOWNEY JM, COHEN MV, 1997. Protection of ischemic preconditioning is dependent upon a critical timing sequence of protein kinase C activation. J Mol Cell Cardiol 29: 991-999.
48. YTREHUS K, LIU Y, DOWNEY JM, 1994. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 266: H1145-H1152.
49. ZANKE BW, RUBIE EA, WINNETT E, CHAN J, RANDALL S, PARSONS M, BOUDREAU K, MCINNIS M, YAN M, TEMPLETON DJ, WOODGETT JR, 1996. Mammalian mitogen-activated protein kinase pathways are regulated through formation of specific kinase-activator complexes. J Biol Chem 271: 29876-29881.